Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24025862 | 1.00 | PDE4D (0.31) | PDE4DGBA1 | |
| SCHEMBL6447297 | 1.00 | PDE4D (0.31) | PDE4DGBA1 | |
| SCHEMBL15424098 | 1.00 | PDE4D (0.31) | PDE4DGBA1 | |
| SCHEMBL4984741 | 1.00 | PDE4D (0.31) | PDE4DGBA1 | |
| SCHEMBL18797772 | 0.79 | SYNJ2 (0.30) | PDE4D | |
| SCHEMBL4436037 | 0.77 | — | — | |
| SCHEMBL14985186 | 0.77 | PDE4D (0.31) | PDE4D | |
| SCHEMBL21842390 | 0.77 | PDE4D (0.31) | PDE4D | |
| SCHEMBL12899666 | 0.77 | GAA (0.31) | PDE4D | |
| SCHEMBL4326330 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7361745-B2 | Process for the preparation of 1-chloro-3,5-di-o-acyl-2-deoxy-l-ribofuranoside derivatives | INALCO S.P.A. (IT) | 2008-04-22 | — | — | US | claimed |
| US-20070083041-A1 | Process for the preparation of 1-chloro-3,5-di-o-acyl-2-deoxy-l-ribofuranoside derivatives | INALCO, S.P.A. (IT) | 2007-04-12 | — | — | US | claimed |
| EP-1699805-A1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-3,5-DI-O-ACYL-2-DEOXY-L-RIBOFURANOSIDE DERIVATIVES | Inalco S.p.A. (IT) | 2006-09-13 | — | — | EP | claimed |
| WO-2005044832-A1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-3,5-DI-O-ACYL-2-DEOXY-L-RIBOFURANOSIDE DERIVATIVES | INALCO S.P.A. (IT) | 2005-05-19 | — | — | WO | claimed |
| EP-1699805-A1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-3,5-DI-O-ACYL-2-DEOXY-L-RIBOFURANOSIDE DERIVATIVES | Inalco S.p.A. (IT) | 2006-09-13 | — | — | EP | disclosed |
| WO-2005044832-A1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-3,5-DI-O-ACYL-2-DEOXY-L-RIBOFURANOSIDE DERIVATIVES | INALCO S.P.A. (IT) | 2005-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070083041-A1 | Process for the preparation of 1-chloro-3,5-di-o-acyl-2-deoxy-l-ribofuranoside derivatives | RNGTT, RNASEL, CPSF7 | PDE4D 3071/4885GBA1 554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.